MicroRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator

Atherosclerosis

Volumn 243, Issue 2, 2015, Pages 523-532

  Jiang, Huajun ^a   Zhang, Jin ^a   Du, Yu ^a   Jia, Xiaojian ^a   Yang, Fan ^a   Si, Shuyi ^a   Wang, Li ^a   Hong, Bin ^a  

^a INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

Author keywords

Cholesterol metabolism; Low density lipoprotein receptor (LDLR); MicroRNA; Posttranscriptional regulation; RNA binding proteins (RBPs)

Indexed keywords

CHOLESTEROL; KH TYPE SPLICING REGULATORY PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; MICRORNA; MICRORNA 185; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; APOLIPOPROTEIN E; BIOLOGICAL MARKER; KHSRP PROTEIN, HUMAN; LDLR PROTEIN, HUMAN; LOW DENSITY LIPOPROTEIN; MIRN185 MICRORNA, HUMAN; MIRN185 MICRORNA, MOUSE; TRANSACTIVATOR PROTEIN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENDOCYTOSIS; GENE OVEREXPRESSION; HEPG2 CELL LINE; HOMEOSTASIS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; AORTA; AORTIC DISEASES; ATHEROSCLEROSIS; BLOOD; C57BL MOUSE; DEFICIENCY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; KNOCKOUT MOUSE; LIVER; MALE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; RNA INTERFERENCE; RNA PROCESSING;

3' UNTRANSLATED REGIONS; ANIMALS; AORTA; AORTIC DISEASES; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BASE SEQUENCE; BIOMARKERS; CHOLESTEROL; DISEASE MODELS, ANIMAL; ENDOCYTOSIS; GENE EXPRESSION REGULATION; HEP G2 CELLS; HUMANS; LIPOPROTEINS, LDL; LIVER; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; MOLECULAR SEQUENCE DATA; PLAQUE, ATHEROSCLEROTIC; RECEPTORS, LDL; RNA INTERFERENCE; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; RNA-BINDING PROTEINS; TRANS-ACTIVATORS; TRANSFECTION;

EID: 84945339933     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.10.026     Document Type: Article

References (40)

1. Mendis S., Puska P., Norrving B. Global Atlas on Cardiovascular Disease Prevention and Control 2011, World Health Organization, Geneva.
2. Downs J.R., Clearfield M., Weis S., Whitney E., Shapiro D.R., Beere P.A., Langendorfer A., Stein E.A., Kruyer W., Gotto A.M. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air force/texas coronary atherosclerosis prevention study. J. Am. Med. Assoc. 1998, 279:1615-1622.
3. Brown M.S., Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science 1986, 232:34-47.
4. Spady D.K. Hepatic clearance of plasma low density lipoproteins. Semin. Liver. Dis. 1992, 12:373-385.
5. Brown M.S., Goldstein J.L. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 1997, 89:331-340.
6. Lagace T.A., Curtis D.E., Garuti R., McNutt M.C., Park S.W., Prather H.B., Anderson N.N., Ho Y.K., Hammer R.E., Horton J.D. Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice. J. Clin. Invest. 2006, 116:2995-3005.
7. Zhang L., Fairall L., Goult B.T., Calkin A.C., Hong C., Millard C.J., Tontonoz P., Schwabe J.W. The IDOL-UBE2D complex mediates sterol-dependent degradation of the LDL receptor. Genes Dev. 2011, 25:1262-1274.
8. Wilson G.M., Vasa M.Z., Deeley R.G. Stabilization and cytoskeletal-association of LDL receptor mRNA are mediated by distinct domains in its 3' untranslated region. J. Lipid. Res. 1998, 39:1025-1032.
9. Li H., Chen W., Zhou Y., Abidi P., Sharpe O., Robinson W.H., Kraemer F.B., Liu J. Identification of mRNA binding proteins that regulate the stability of LDL receptor mRNA through AU-rich elements. J. Lipid. Res. 2009, 50:820-831.
10. Yashiro T., Nanmoku M., Shimizu M., Inoue J., Sato R. 5-Aminoimidazole-4-carboxamide ribonucleoside stabilizes low density lipoprotein receptor mRNA in hepatocytes via ERK-dependent HuR binding to an AU-rich element. Atherosclerosis 2013, 226:95-101.
11. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
12. Winter J., Jung S., Keller S., Gregory R.I., Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat. Cell Biol. 2009, 11:228-234.
13. Elmen J., Lindow M., Schutz S., Lawrence M., Petri A., Obad S., Lindholm M., Hedtjarn M., Hansen H.F., Berger U., Gullans S., Kearney P., Sarnow P., Straarup E.M., Kauppinen S. LNA-mediated microRNA silencing in non-human primates. Nature 2008, 452:896-899.
14. Elmen J., Lindow M., Silahtaroglu A., Bak M., Christensen M., Lind-Thomsen A., Hedtjarn M., Hansen J.B., Hansen H.F., Straarup E.M., McCullagh K., Kearney P., Kauppinen S. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic. Acids Res. 2008, 36:1153-1162.
15. Esau C., Davis S., Murray S.F., Yu X.X., Pandey S.K., Pear M., Watts L., Booten S.L., Graham M., McKay R., Subramaniam A., Propp S., Lollo B.A., Freier S., Bennett C.F., Bhanot S., Monia B.P. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 2006, 3:87-98.
16. Krutzfeldt J., Rajewsky N., Braich R., Rajeev K.G., Tuschl T., Manoharan M., Stoffel M. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005, 438:685-689.
17. Rayner K.J., Sheedy F.J., Esau C.C., Hussain F.N., Temel R.E., Parathath S., van Gils J.M., Rayner A.J., Chang A.N., Suarez Y., Fernandez-Hernando C., Fisher E.A., Moore K.J. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J. Clin. Invest. 2011, 121:2921-2931.
18. Rayner K.J., Esau C.C., Hussain F.N., McDaniel A.L., Marshall S.M., van Gils J.M., Ray T.D., Sheedy F.J., Goedeke L., Liu X., Khatsenko O.G., Kaimal V., Lees C.J., Fernandez-Hernando C., Fisher E.A., Temel R.E., Moore K.J. Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature 2011, 478:404-407.
19. Rayner K.J., Suarez Y., Davalos A., Parathath S., Fitzgerald M.L., Tamehiro N., Fisher E.A., Moore K.J., Fernandez-Hernando C. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 2010, 328:1570-1573.
20. Najafi-Shoushtari S.H., Kristo F., Li Y., Shioda T., Cohen D.E., Gerszten R.E., Naar A.M. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 2010, 328:1566-1569.
21. Marquart T.J., Allen R.M., Ory D.S., Baldan A. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:12228-12232.
22. Wang L., Jia X.J., Jiang H.J., Du Y., Yang F., Si S.Y., Hong B. MicroRNAs 185, 96, and 223 repress selective high-density lipoprotein cholesterol uptake through posttranscriptional inhibition. Mol. Cell. Biol. 2013, 33:1956-1964.
23. Yang M., Liu W., Pellicane C., Sahyoun C., Joseph B.K., Gallo-Ebert C., Donigan M., Pandya D., Giordano C., Bata A., Nickels J.T. Identification of miR-185 as a regulator of de novo cholesterol biosynthesis and low density lipoprotein uptake. J. Lipid. Res. 2014, 55:226-238.
24. Bao Y., Wang L., Xu Y., Yang Y., Si S., Cho S., Hong B. Salvianolic acid B inhibits macrophage uptake of modified low density lipoprotein (mLDL) in a scavenger receptor CD36-dependent manner. Atherosclerosis 2012, 223:152-159.
25. Zhang Z., Luo X., Ding S., Chen J., Chen T., Chen X., Zha H., Yao L., He X., Peng H. MicroRNA-451 regulates p38 MAPK signaling by targeting of Ywhaz and suppresses the mesangial hypertrophy in early diabetic nephropathy. Febs. Lett. 2012, 586:20-26.
26. Bao Y., Yang Y., Wang L., Gao L., Jiang W., Si S., Hong B. Identification of trichostatin A as a novel transcriptional up-regulator of scavenger receptor BI both in HepG2 and RAW 264.7 cells. Atherosclerosis 2009, 204:127-135.
27. Kozomara A., Griffiths-Jones S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic. Acids Res. 2014, 42:D68-D73.
28. Garcia D.M., Baek D., Shin C., Bell G.W., Grimson A., Bartel D.P. Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs. Nat. Struct. Mol. Biol. 2011, 18:1139-1146.
29. Betel D., Wilson M., Gabow A., Marks D.S., Sander C. The microRNA.org resource: targets and expression. Nucleic. Acids. Res. 2008, 36:D149-D153.
30. Betel D., Koppal A., Agius P., Sander C., Leslie C. Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol. 2010, 11:R90.
31. Siepel A., Bejerano G., Pedersen J.S., Hinrichs A.S., Hou M., Rosenbloom K., Clawson H., Spieth J., Hillier L.W., Richards S., Weinstock G.M., Wilson R.K., Gibbs R.A., Kent W.J., Miller W., Haussler D. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res. 2005, 15:1034-1050.
32. Hassan M.Q., Gordon J.A., Lian J.B., van Wijnen A.J., Stein J.L., Stein G.S. Ribonucleoprotein immunoprecipitation (RNP-IP): a direct in vivo analysis of microRNA-targets. J. Cell Biochem. 2010, 110:817-822.
33. Feil S., Hofmann F., Feil R. SM22alpha modulates vascular smooth muscle cell phenotype during atherogenesis. Circ. Res. 2004, 94:863-865.
34. Goedeke L., Fernandez-Hernando C. Regulation of cholesterol homeostasis. Cell Mol. Life Sci. 2012, 69:915-930.
35. Serva A., Knapp B., Tsai Y.T., Claas C., Lisauskas T., Matula P., Harder N., Kaderali L., Rohr K., Erfle H., Eils R., Braga V., Starkuviene V. miR-17-5p regulates endocytic trafficking through targeting TBC1D2/Armus. PLoS One 2013, 7:e52555.
36. Liang Y., Ridzon D., Wong L., Chen C. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 2007, 8:166.
37. Alon U. Network motifs: theory and experimental approaches. Nat. Rev. Genet. 2007, 8:450-461.
38. Mangan S., Alon U. Structure and function of the feed-forward loop network motif. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:11980-11985.
39. Osella M., Bosia C., Cora D., Caselle M. The role of incoherent microRNA-mediated feedforward loops in noise buffering. PLoS Comput. Biol. 2011, 7:e1001101.
40. Joshi A., Beck Y., Michoel T. Post-transcriptional regulatory networks play a key role in noise reduction that is conserved from micro-organisms to mammals. FEBS J. 2012, 279:3501-3512.